Search

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.

Why cell and gene therapy manufacturing has a lot to learn from the automotive sector.

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

The public’s perception of the industry is low. How can we fix it?

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.

As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.

It’s time to go back to basics when it comes to pharmaceutical supply chains and preventing shortages.

The latest X-ray technology goes beyond foreign body detection, ensuring each dose is right first time – every time.

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.

We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.